Literature DB >> 18815307

Mutational analysis of cis-acting RNA signals in segment 7 of influenza A virus.

Edward C Hutchinson1, Martin D Curran, Eliot K Read, Julia R Gog, Paul Digard.   

Abstract

The genomic viral RNA (vRNA) segments of influenza A virus contain specific packaging signals at their termini that overlap the coding regions. To further characterize cis-acting signals in segment 7, we introduced synonymous mutations into the terminal coding regions. Mutation of codons that are normally highly conserved reduced virus growth in embryonated eggs and MDCK cells between 10- and 1,000-fold compared to that of the wild-type virus, whereas similar alterations to nonconserved codons had little effect. In all cases, the growth-impaired viruses showed defects in virion assembly and genome packaging. In eggs, nearly normal numbers of virus particles that in aggregate contained apparently equimolar quantities of the eight segments were formed, but with about fourfold less overall vRNA content than wild-type virions, suggesting that, on average, fewer than eight segments per particle were packaged. Concomitantly, the particle/PFU and segment/PFU ratios of the mutant viruses showed relative increases of up to 300-fold, with the behavior of the most defective viruses approaching that predicted for random segment packaging. Fluorescent staining of infected cells for the nucleoprotein and specific vRNAs confirmed that most mutant virus particles did not contain a full genome complement. The specific infectivity of the mutant viruses produced by MDCK cells was also reduced, but in this system, the mutations also dramatically reduced virion production. Overall, we conclude that segment 7 plays a key role in the influenza A virus genome packaging process, since mutation of as few as 4 nucleotides can dramatically inhibit infectious virus production through disruption of vRNA packaging.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18815307      PMCID: PMC2583641          DOI: 10.1128/JVI.01634-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Three-dimensional reconstruction of a recombinant influenza virus ribonucleoprotein particle.

Authors:  J Martín-Benito; E Area; J Ortega; O Llorca; J M Valpuesta; J L Carrascosa; J Ortín
Journal:  EMBO Rep       Date:  2001-04       Impact factor: 8.807

2.  Influenza A virus can undergo multiple cycles of replication without M2 ion channel activity.

Authors:  T Watanabe; S Watanabe; H Ito; H Kida; Y Kawaoka
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

3.  Evidence for specific packaging of the influenza A virus genome from conditionally defective virus particles lacking a polymerase gene.

Authors:  Emmie de Wit; Monique I J Spronken; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  Vaccine       Date:  2006-06-21       Impact factor: 3.641

4.  Distinct domains of the influenza a virus M2 protein cytoplasmic tail mediate binding to the M1 protein and facilitate infectious virus production.

Authors:  Matthew F McCown; Andrew Pekosz
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

5.  Approximately 150 nucleotides from the 5' end of an influenza A segment 1 defective virion RNA are needed for genome stability during passage of defective virus in infected cells.

Authors:  S Duhaut; N J Dimmock
Journal:  Virology       Date:  2000-09-30       Impact factor: 3.616

6.  The influenza A virus M2 cytoplasmic tail is required for infectious virus production and efficient genome packaging.

Authors:  Matthew F McCown; Andrew Pekosz
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

7.  The cytoplasmic tail of the influenza A virus M2 protein plays a role in viral assembly.

Authors:  Kiyoko Iwatsuki-Horimoto; Taisuke Horimoto; Takeshi Noda; Maki Kiso; Junko Maeda; Shinji Watanabe; Yukiko Muramoto; Ken Fujii; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

8.  Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture.

Authors:  Makoto Takeda; Andrew Pekosz; Kevin Shuck; Lawrence H Pinto; Robert A Lamb
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

9.  New low-viscosity overlay medium for viral plaque assays.

Authors:  Mikhail Matrosovich; Tatyana Matrosovich; Wolfgang Garten; Hans-Dieter Klenk
Journal:  Virol J       Date:  2006-08-31       Impact factor: 4.099

10.  Temperature sensitive influenza A virus genome replication results from low thermal stability of polymerase-cRNA complexes.

Authors:  Rosa M Dalton; Anne E Mullin; Maria Joao Amorim; Elizabeth Medcalf; Laurence S Tiley; Paul Digard
Journal:  Virol J       Date:  2006-08-25       Impact factor: 4.099

View more
  79 in total

1.  Computational and molecular analysis of conserved influenza A virus RNA secondary structures involved in infectious virion production.

Authors:  Yuki Kobayashi; Bernadeta Dadonaite; Neeltje van Doremalen; Yoshiyuki Suzuki; Wendy S Barclay; Oliver G Pybus
Journal:  RNA Biol       Date:  2016-07-11       Impact factor: 4.652

2.  The influenza A virus PB2, PA, NP, and M segments play a pivotal role during genome packaging.

Authors:  Qinshan Gao; Yi-Ying Chou; Sultan Doğanay; Reza Vafabakhsh; Taekjip Ha; Peter Palese
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

3.  Nucleotide sequence requirements at the 5' end of the influenza A virus M RNA segment for efficient virus replication.

Authors:  Makoto Ozawa; Junko Maeda; Kiyoko Iwatsuki-Horimoto; Shinji Watanabe; Hideo Goto; Taisuke Horimoto; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2009-01-21       Impact factor: 5.103

4.  The genome-packaging signal of the influenza A virus genome comprises a genome incorporation signal and a genome-bundling signal.

Authors:  Hideo Goto; Yukiko Muramoto; Takeshi Noda; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2013-08-07       Impact factor: 5.103

5.  Critical role of segment-specific packaging signals in genetic reassortment of influenza A viruses.

Authors:  Boris Essere; Matthieu Yver; Cyrille Gavazzi; Olivier Terrier; Catherine Isel; Emilie Fournier; Fabienne Giroux; Julien Textoris; Thomas Julien; Clio Socratous; Manuel Rosa-Calatrava; Bruno Lina; Roland Marquet; Vincent Moules
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

6.  The Rab11 pathway is required for influenza A virus budding and filament formation.

Authors:  Emily A Bruce; Paul Digard; Amanda D Stuart
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

7.  Biological activities of 'noninfectious' influenza A virus particles.

Authors:  Christopher B Brooke
Journal:  Future Virol       Date:  2014-01       Impact factor: 1.831

8.  RAB11A is essential for transport of the influenza virus genome to the plasma membrane.

Authors:  Amie J Eisfeld; Eiryo Kawakami; Tokiko Watanabe; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2011-04-27       Impact factor: 5.103

9.  A Rab11- and microtubule-dependent mechanism for cytoplasmic transport of influenza A virus viral RNA.

Authors:  Maria Joao Amorim; Emily A Bruce; Eliot K C Read; Agnes Foeglein; Robert Mahen; Amanda D Stuart; Paul Digard
Journal:  J Virol       Date:  2011-02-09       Impact factor: 5.103

10.  Incorporation of influenza A virus genome segments does not absolutely require wild-type sequences.

Authors:  Ken Fujii; Makoto Ozawa; Kiyoko Iwatsuki-Horimoto; Taisuke Horimoto; Yoshihiro Kawaoka
Journal:  J Gen Virol       Date:  2009-03-18       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.